Author： Severens Johan L. Brunenberg Daniëlle E.M.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.23, Iss.12, 2005-01, pp. : 1207-1214
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio
By O'Hagan A.
PharmacoEconomics, Vol. 17, Iss. 4, 2000-04 ,pp. :
Access to resources
Recommend
Cost–effectiveness analysis in pharmacogenomics
By Payne Katherine Shabaruddin Fatiha H
Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. :
Estimating `Costs' for Cost-Effectiveness Analysis
By Miners Alec
PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. :
Handling Uncertainty in Cost-Effectiveness Models
By Briggs A.H.
PharmacoEconomics, Vol. 17, Iss. 5, 2000-05 ,pp. :